We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure coreplatform@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Cancer staging refers to the classification of patients based on the anatomic extent of disease. The Tumor Node Metastasis (TNM) classification evolved from the work of Pierre Denoix in the 1940s and has since been adopted as the reference standard by the International Union Against Cancer (Union Internationale Contre le Cancer – UICC) and the American Joint Committee on Cancer (AJCC). These two bodies collaborate to ensure a uniform TNM classification. The most recent classification, the seventh edition, was published in 2009. This revision contains the first changes since the 1997 fifth edition. The changes were based upon proposals submitted by the International Association for the Study of Lung Cancer (IASLC). The seventh edition will be used throughout this chapter, with reference to the sixth edition where necessary to highlight important changes.
The TNM Classification fulfills a number of related objectives, namely:
To aid the clinician in the planning of treatment.
To give some indication of prognosis.
To assist in evaluation of the results of treatment.
To facilitate the exchange of information between treatment centers.
To contribute to the continuing investigation of human cancer.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.